GEMTUZUMAB OZOGAMICIN FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA IN CHILDREN - SINGLE CENTER EXPERIENCE

被引:0
|
作者
Pawinska-Wasikowska, Katarzyna [1 ,2 ,3 ]
Czogala, Malgorzata [1 ,2 ,4 ]
Bukowska-Strakova, Karolina [5 ]
Ksiazek, Teofila [6 ,7 ]
Skoczen, Szymon [1 ,2 ]
Balwierz, Walentyna [1 ,2 ]
机构
[1] Jagiellonian Univ, Med Coll, Inst Pediat, PL-31663 Krakow, Poland
[2] Dept Pediat Oncol & Hematol, Krakow, Poland
[3] Univ Childrens Hosp Krakow, Dept Oncol & Hematol, Krakow, Poland
[4] Univ Childrens Hosp Krakow, Dept Childrens Oncol & Hematol, Krakow, Poland
[5] Jagiellonian Univ, Med Coll, Inst Pediat, Dept Clin Immunol, Krakow, Poland
[6] Jagiellonian Univ, Inst Pediat, Med Coll, PL-31663 Krakow, Poland
[7] Dept Mol Genet, Krakow, Poland
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PO043
引用
收藏
页码:S584 / S585
页数:2
相关论文
共 50 条
  • [1] Gemtuzumab ozogamicin (Mylotarg®) in children with refractory or relapsed acute myeloid leukemia
    Reinhardt, D
    Diekamp, S
    Fleischhack, G
    Corbacioglu, S
    Jürgens, H
    Dworzak, M
    Kaspers, G
    Creutzig, U
    Zwaan, CM
    [J]. ONKOLOGIE, 2004, 27 (03): : 269 - 272
  • [2] Gemtuzumab ozogamicin for relapsed and refractory acute myeloid leukemia and myeloid sarcomas
    Piccaluga, PP
    Martinelli, G
    Rondoni, M
    Malagola, M
    Gaitani, S
    Isidori, A
    Bonini, A
    Gugliotta, L
    Luppi, M
    Morselli, M
    Sparaventi, G
    Visani, G
    Baccarani, M
    [J]. LEUKEMIA & LYMPHOMA, 2004, 45 (09) : 1791 - 1795
  • [3] Gemtuzumab Ozogamicin Containing Chemotherapy for Relapsed or Refractory Acute Myeloid Leukemia (AML) in Children
    Liu, Anthony Pak-Yin
    Leung, Alex Wing-Kwan
    Cheuk, Daniel Ka-Leung
    Lee, Vincent
    Ha, Shau-Yin
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2018, 40 (02) : 163 - 168
  • [4] Azacitidine combined with gemtuzumab ozogamicin in patients with relapsed/refractory acute myeloid leukemia
    Bayraktar, Ulas Darda
    Domingo, Gelenis Calzadilla
    Schmit, Jessica
    Pereira, Denise
    [J]. LEUKEMIA & LYMPHOMA, 2011, 52 (05) : 913 - 915
  • [5] Gemtuzumab ozogamicin in combination with intensive chemotherapy in relapsed or refractory acute myeloid leukemia
    Chantepie, Sylvain P.
    Reboursiere, Emilie
    Mear, Jean-Baptiste
    Gac, Anne-Claire
    Salaun, Veronique
    Benabed, Khaled
    Cheze, Stephane
    Johnsonansah, Hyacinthe
    Macro, Margaret
    Vilque, Jean-Pierre
    Reman, Oumedaly
    [J]. LEUKEMIA & LYMPHOMA, 2015, 56 (08) : 2326 - 2330
  • [6] Clinical outcomes of gemtuzumab ozogamicin for relapsed acute myeloid leukemia: single-institution experience
    Naoko Hosono
    Miyuki Ookura
    Hiroaki Araie
    Mihoko Morita
    Kazuhiro Itoh
    Yasufumi Matsuda
    Takahiro Yamauchi
    [J]. International Journal of Hematology, 2021, 113 : 362 - 369
  • [7] Clinical outcomes of gemtuzumab ozogamicin for relapsed acute myeloid leukemia: single-institution experience
    Hosono, Naoko
    Ookura, Miyuki
    Araie, Hiroaki
    Morita, Mihoko
    Itoh, Kazuhiro
    Matsuda, Yasufumi
    Yamauchi, Takahiro
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 113 (03) : 362 - 369
  • [8] GEMTUZUMAB OZOGAMICIN FOR RELAPSED OR PRIMARY REFRACTORY ACUTE MYELOID LEUKEMIA IN CHILDREN - EXPERIENCE OF THE POLISH PEDIATRIC LEUKEMIA AND LYMPHOMA STUDY GROUP (PPLLSG)
    Pawinska-Wasikowska, Katarzyna
    Bukowska-Strakova, Karolina
    Czogala, Malgorzata
    Wachowiak, Jacek
    Chaber, Radoslaw
    Szczepanski, Tomasz
    [J]. PEDIATRIC BLOOD & CANCER, 2023, 70
  • [9] Gemtuzumab ozogamicin for relapsed or primary refractory acute myeloid leukemia in children-the Polish Pediatric Leukemia and Lymphoma Study Group experience
    Pawinska-Wasikowska, Katarzyna
    Czogala, Malgorzata
    Skoczen, Szymon
    Surman, Marta
    Rygielska, Monika
    Ksiazek, Teofila
    Pac, Agnieszka
    Wieczorek, Aleksandra
    Skalska-Sadowska, Jolanta
    Samborska, Magdalena
    Wachowiak, Jacek
    Chaber, Radoslaw
    Tomaszewska, Renata
    Szczepanski, Tomasz
    Zielezinska, Karolina
    Urasinski, Tomasz
    Moj-Hackemer, Malgorzata
    Kalwak, Krzysztof
    Kozlowska, Marta
    Irga-Jaworska, Ninela
    Balwierz, Walentyna
    Bukowska-Strakova, Karolina
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [10] Gemtuzumab ozogamicin with FLAG-IDA is effective for children in relapsed/refractory acute myeloid leukemia.
    Cho, Bin
    Kim, Sun Young
    Lee, Dae Hyoung
    Kwon, Young Joo
    Park, Young Shil
    Hwang, Hui Sung
    Park, Ji Kyoung
    Jang, Pil Sang
    Chung, Nak Gyun
    Jeong, Dae-Chul
    Kim, Hack Ki
    [J]. BLOOD, 2006, 108 (11) : 218B - 218B